Total Payments
$20,986
2024 Payments
$2,759
Companies
42
Transactions
965
Medicare Patients
2,273
Medicare Billing
$704,561
Payment Breakdown by Category
Food & Beverage$20,810 (99.2%)
Education$118.38 (0.6%)
Gifts$57.25 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,810 | 953 | 99.2% |
| Education | $118.38 | 8 | 0.6% |
| Gift | $57.25 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $2,631 | 156 | $0 (2022) |
| Validus Pharmaceuticals LLC | $1,974 | 29 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,741 | 85 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,642 | 73 | $0 (2024) |
| Lundbeck LLC | $1,522 | 72 | $0 (2024) |
| Alkermes, Inc. | $1,398 | 46 | $0 (2024) |
| ABBVIE INC. | $1,310 | 69 | $0 (2024) |
| Allergan, Inc. | $859.18 | 39 | $0 (2020) |
| ITI, Inc. | $835.92 | 42 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $816.97 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,759 | 133 | Lundbeck LLC ($386.95) |
| 2023 | $2,788 | 128 | AbbVie Inc. ($490.72) |
| 2022 | $2,902 | 118 | Alkermes, Inc. ($490.84) |
| 2021 | $4,007 | 138 | Validus Pharmaceuticals LLC ($1,316) |
| 2020 | $2,356 | 120 | Sunovion Pharmaceuticals Inc. ($512.80) |
| 2019 | $1,834 | 105 | Sunovion Pharmaceuticals Inc. ($476.51) |
| 2018 | $2,270 | 118 | Sunovion Pharmaceuticals Inc. ($482.38) |
| 2017 | $2,070 | 105 | Sunovion Pharmaceuticals Inc. ($666.13) |
All Payment Transactions
965 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CNS | ||||||
| 11/13/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Addiction Medicine | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $123.80 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ADHD | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: CNS | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 508 | 2,345 | $399,310 | $160,634 |
| 2022 | 3 | 504 | 2,534 | $401,076 | $178,466 |
| 2021 | 5 | 632 | 2,680 | $402,730 | $198,070 |
| 2020 | 5 | 629 | 2,451 | $377,430 | $167,392 |
Total Patients
2,273
Total Services
10,010
Medicare Billing
$704,561
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 1,204 | $222,800 | $92,257 | 41.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 239 | 1,095 | $164,250 | $63,382 | 38.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,010 | $2,658 | 53.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 12 | 33 | $7,250 | $2,336 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 245 | 1,292 | $226,010 | $101,667 | 45.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 245 | 1,228 | $170,026 | $73,814 | 43.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $5,040 | $2,985 | 59.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 280 | 1,339 | $220,995 | $108,083 | 48.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 273 | 1,243 | $155,375 | $75,202 | 48.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $17,150 | $10,013 | 58.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 22 | $5,160 | $2,580 | 50.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 18 | 27 | $4,050 | $2,192 | 54.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 247 | 1,213 | $200,205 | $80,297 | 40.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 241 | 1,053 | $131,625 | $65,433 | 49.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 60 | 60 | $21,000 | $10,679 | 50.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 76 | $17,250 | $7,276 | 42.2% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 27 | 49 | $7,350 | $3,706 | 50.4% |
About Dr. Robert Castroll, MD
Dr. Robert Castroll, MD is a Psychiatry healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407929003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Castroll, MD has received a total of $20,986 in payments from pharmaceutical and medical device companies, with $2,759 received in 2024. These payments were reported across 965 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($20,810).
As a Medicare-enrolled provider, Castroll has provided services to 2,273 Medicare beneficiaries, totaling 10,010 services with total Medicare billing of $704,561. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Smithtown, NY
- Active Since 11/15/2006
- Last Updated 01/28/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1407929003
Products in Payments
- LATUDA (Drug) $2,631
- REXULTI (Drug) $2,113
- VRAYLAR (Drug) $1,976
- Equetro (Drug) $1,974
- AUSTEDO (Drug) $1,241
- CAPLYTA (Drug) $1,099
- ARISTADA (Drug) $998.30
- TRINTELLIX (Drug) $895.87
- INGREZZA (Drug) $763.52
- ABILIFY MAINTENA (Drug) $739.16
- BELSOMRA (Drug) $564.00
- Sunosi (Drug) $530.08
- Austedo XR (Drug) $370.19
- SPRAVATO (Drug) $307.46
- QUVIVIQ (Drug) $248.27
- LYBALVI (Drug) $235.99
- SUNOSI (Drug) $234.52
- HETLIOZ (Drug) $229.77
- APLENZIN (Drug) $217.12
- NEUROSTAR TMS THERAPY (Device) $202.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Smithtown
Bruce Rosen, Md, MD
Psychiatry — Payments: $46,082
Psychiatry $46,082
Shelley Epstein, Md, MD
Psychiatry — Payments: $13,002
Psychiatry $13,002
Suzanne Tuzel, Md, MD
Psychiatry — Payments: $9,906
Psychiatry $9,906
Dr. Maria Benetos, Do, DO
Psychiatry — Payments: $3,293
Psychiatry $3,293
Dr. Christopher Burke, M.d, M.D
Psychiatry — Payments: $1,541
Psychiatry $1,541
Dr. Devendra Amin, M.d, M.D
Psychiatry — Payments: $1,466
Psychiatry $1,466